Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1988-6-2
pubmed:abstractText
To provide an effective continuum of the relief of severe carcinomatous pain with minimal side reactions, we initiated treatment with piroxicam (60 to 120 mg per day) and doxepin hydrochloride (25 to 225 mg per day). Of 30 patients presenting with severe pain of cancer of various origins, 7 continued to death with piroxicam and doxepin therapy. An additional 17 were successfully treated for 6 to 66 weeks with therapy reported here but, as disease progressed, required supplemental narcotics. The remaining six abandoned the use of piroxicam due to complications of therapy, which ranged from diarrhea to gastric perforation; serious complications were associated with patients' failure to adhere to a prescribed regimen of sucralfate. Therapy with piroxicam and doxepin proved to be safe and efficacious.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-2418050, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-2582259, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-2856923, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-2872994, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3511376, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3718091, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3802043, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3834587, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3903613, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3914701, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3914702, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3914703, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3917708, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3919745, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-3946946, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6141628, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6198700, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6363936, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6388415, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6695095, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-6695566, http://linkedlifedata.com/resource/pubmed/commentcorrection/3363962-7002189
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0093-0415
pubmed:author
pubmed:issnType
Print
pubmed:volume
148
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
303-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Piroxicam and doxepin--an alternative to narcotic analgesics in managing advanced cancer pain.
pubmed:publicationType
Journal Article